Pharmacists will now see their profit margins adjusted in line with price increases due to exchange rate updates. The Ministry of Health released a statement regarding the regulation published in the Official Gazette yesterday, noting that drug prices are updated annually based on the periodic exchange rate changes for the Euro and in accordance with the “Regulation on Pricing of Human Medicinal Products.” It was emphasized that this update is determined based on a specific percentage of the average Euro value of the previous year within the framework of budget discipline, including not only domestic but also imported drugs. Due to the lack of annual updates in the current regulation, it was stated in the announcement that pharmacy profit margins have remained stagnant, leading to many drugs being sold at lower profitability rates by moving to the upper limit. The statement revealed that pharmacists’ profitability tiers are applied as 28% for first-tier drugs (up to 328 liras), 18% for second-tier drugs (328-657 liras), and 13% for third-tier drugs (over 657 liras). The regulation published in the Official Gazette yesterday was described in the announcement as providing significant benefit to pharmacists, stating, “Pharmacists’ profitability tiers will now be recalibrated with each exchange rate update period. This means that the essential drug price tiers for pharmacists’ profits will increase proportionally with updates to drug prices. Pharmacists will benefit equally from drug price increases, preventing income losses.”